Hologic (LTS:0J5Q) Inventories, Finished Goods : $0 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Hologic Inventories, Finished Goods?

Hologic's quarterly finished goods declined from Sep. 2023 ($313 Mil) to Dec. 2023 ($309 Mil) and declined from Dec. 2023 ($309 Mil) to Mar. 2024 ($0 Mil).

Hologic's annual finished goods increased from Sep. 2021 ($285 Mil) to Sep. 2022 ($311 Mil) and increased from Sep. 2022 ($311 Mil) to Sep. 2023 ($313 Mil).

Hologic Inventories, Finished Goods Historical Data

The historical data trend for Hologic's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hologic Inventories, Finished Goods Chart

Hologic Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Inventories, Finished Goods

Get a 7-Day Free Trial

224.30

196.30

284.90

310.70

312.70

Hologic Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial															328.50	353.10	312.70	309.20	-

Hologic Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Hologic (LTS:0J5Q) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hologic Inc (LTS:0J5Q) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

HOLX:USA HOLX:Mexico HO1:Germany HOLX:Austria

Address

250 Campus Drive, Marlborough, MA, USA, 01752

Website

http://www.hologic.com

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Hologic (LTS:0J5Q) Headlines

No Headlines